Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

20032,507 citationsJournal Articlebronze Open Access

Authors

Agnes Lee · McMaster University

Mark N. Levine · McMaster University

Ross Baker · University of Western Australia

Chris Bowden

Ajay K. Kakkar · Imperial College London

Martin H. Prins · Maastricht University Medical Centre

Frederick R. Rickles

Jim A. Julian

Abstract

In patients with cancer and acute venous thromboembolism, dalteparin was more effective than an oral anticoagulant in reducing the risk of recurrent thromboembolism without increasing the risk of bleeding.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Central Venous Catheters and Hemodialysis Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 349, Issue 2, pp. 146-153

DOI: 10.1056/nejmoa025313

Field-Weighted Citation Impact: 51.19